Morgan Stanley
CYRX icon

Morgan Stanley’s CryoPort CYRX Stock Holding History

Morgan Stanley’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.9M Sell
4,576,730
-10,814
-0.2% -$97.7K ﹤0.01% 2376
2025
Q4 		$44M Sell
4,587,544
-23,463
-0.5% -$222K ﹤0.01% 2208
2025
Q3 		$43.7M Buy
4,611,007
+36,883
+0.8% +$310K ﹤0.01% 2117
2025
Q2 		$34.1M Sell
4,574,124
-57,523
-1% -$357K ﹤0.01% 2273
2025
Q1 		$28.2M Sell
4,631,647
-28,830
-0.6% -$199K ﹤0.01% 2344
2024
Q4 		$36.3M Sell
4,660,477
-4,538
-0.1% -$33.8K ﹤0.01% 2137
2024
Q3 		$37.8M Sell
4,665,015
-29,396
-0.6% -$241K ﹤0.01% 2124
2024
Q2 		$32.4M Buy
4,694,411
+283,985
+6% +$3.82M ﹤0.01% 2156
2024
Q1 		$78.1M Sell
4,410,426
-3,932,644
-47% -$62.3M 0.01% 1357
2023
Q4 		$129M Buy
8,343,070
+6,817,991
+447% +$89.1M 0.01% 1478
2023
Q3 		$20.9M Buy
1,525,079
+1,237,953
+431% +$18.2M ﹤0.01% 2406
2023
Q2 		$4.95M Buy
287,126
+81,616
+40% +$1.67M ﹤0.01% 3785
2023
Q1 		$4.93M Sell
205,510
-60,361
-23% -$1.31M ﹤0.01% 3803
2022
Q4 		$4.61M Sell
265,871
-125,581
-32% -$2.65M ﹤0.01% 3822
2022
Q3 		$9.54M Sell
391,452
-53,540
-12% -$1.84M ﹤0.01% 3027
2022
Q2 		$13.8M Buy
444,992
+239,380
+116% +$6.37M ﹤0.01% 2701
2022
Q1 		$7.18M Sell
205,612
-288,781
-58% -$10.9M ﹤0.01% 3285
2021
Q4 		$29.3M Buy
494,393
+150,646
+44% +$10.4M ﹤0.01% 1764
2021
Q3 		$22.9M Buy
343,747
+21,844
+7% +$1.35M ﹤0.01% 1950
2021
Q2 		$20.3M Buy
321,903
+54,375
+20% +$3.06M ﹤0.01% 2129
2021
Q1 		$13.9M Buy
267,528
+51,770
+24% +$3.15M ﹤0.01% 2304
2020
Q4 		$9.47M Sell
215,758
-22,679
-10% -$1.08M ﹤0.01% 2568
2020
Q3 		$11.3M Buy
238,437
+121,630
+104% +$4.93M ﹤0.01% 1922
2020
Q2 		$3.53M Sell
116,807
-8,633
-7% -$192K ﹤0.01% 3033
2020
Q1 		$2.14M Sell
125,440
-28,802
-19% -$504K ﹤0.01% 3306
2019
Q4 		$2.54M Sell
154,242
-396,343
-72% -$5.9M ﹤0.01% 3848
2019
Q3 		$9.01M Buy
550,585
+359,600
+188% +$7.21M ﹤0.01% 2237
2019
Q2 		$3.5M Buy
190,985
+55,969
+41% +$888K ﹤0.01% 3284
2019
Q1 		$1.74M Sell
135,016
-28,683
-18% -$312K ﹤0.01% 3699
2018
Q4 		$1.81M Buy
163,699
+14,389
+10% +$156K ﹤0.01% 3849
2018
Q3 		$1.91M Sell
149,310
-2,001
-1% -$28.6K ﹤0.01% 4040
2018
Q2 		$2.39M Buy
151,311
+76,010
+101% +$809K ﹤0.01% 3906
2018
Q1 		$648K Buy
75,301
+1,766
+2% +$15.6K ﹤0.01% 4841
2017
Q4 		$632K Buy
73,535
+34,715
+89% +$272K ﹤0.01% 4842
2017
Q3 		$382K Buy
38,820
+32,820
+547% +$241K ﹤0.01% 5033
2017
Q2 		$30K Sell
6,000
-3,850
-39% -$12.6K ﹤0.01% 5994
2017
Q1 		$23K Buy
9,850
+1,900
+24% +$6.24K ﹤0.01% 6044
2016
Q4 		$26K Buy
7,950
+1,550
+24% +$3.77K ﹤0.01% 5935
2016
Q3 		$13K Sell
6,400
-7,811
-55% -$15.4K ﹤0.01% 6044
2016
Q2 		$29K Buy
14,211
+9,990
+237% +$20K ﹤0.01% 5718
2016
Q1 		$9K Buy
4,221
+2,208
+110% +$3.88K ﹤0.01% 6157
2015
Q4 		$4K Buy
2,013
+13
+0.7% +$33 ﹤0.01% 6409
2015
Q3 		$5K Buy
+2,000
New +$5.65K ﹤0.01% 6373

Other funds holding CYRX

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley's CYRX Position: Q1 2026 in Review

Morgan Stanley reduced its CryoPort (CYRX) stake by 0.24% in Q1 2026, selling an estimated $97.7K and leaving 4,576,730 shares worth $37.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Morgan Stanley first reported a position in CYRX in Q3 2015 and has held it in 43 quarters since. The position peaked at $129M in Q4 2023. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

  • Morgan Stanley held 4,576,730 shares of CryoPort worth $37.9M as of Q1 2026.
  • Morgan Stanley sold 10,814 CryoPort shares in Q1 2026, an estimated $97.7K.
  • CryoPort made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2376 holding.
  • Morgan Stanley first reported a position in CryoPort in Q3 2015 and has held it in 43 quarters since.
  • Morgan Stanley's CryoPort position peaked at $129M in Q4 2023.
  • 165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.